Yes even if we did 500 million a year in revenue or any otc company for that matter, brokers can’t recommend, analysts can’t cover, investment banks of high caliber don’t let you use their name, money raising deals suck and are the worst, and the list goes on and on and on and on and on!
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links